FORT WORTH – Alcon announced on Monday a partnership with Cooper Kupp, L.A. Rams wide receiver and Super Bowl LVI MVP, to share his experience with eye allergies and help other eye allergy sufferers find relief with Pataday Once Daily Relief Extra Strength. This year’s campaign, The Right Tool for the Job, highlights Kupp’s personal
FORTH WORTH, Texas — Alcon has announced a partnership with actress Kate Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, to share her journey with dry eye around the launch of its Systane Complete Preservative-Free Lubricant Eye Drops. As part of the new Make Every Look Count campaign, Walsh will
GENEVA – Alcon announced Wednesday the European roll out of the newest addition to its innovative portfolio of dry eye products – Systane Complete Preservative-Free Lubricant Eye Drops, now in an easy-to-use, multi-dose bottle. Systane is the leading global artificial tear brand. With the launch of Systane Complete Preservative-Free, Alcon now offers a full portfolio of preservative-free
FRISCO, Texas – Complexity Gaming, one of North America’s most elite and longest-standing esports organizations, announced on Thursday a partnership with Alcon, a global leader in eye care. The partnership will designate Alcon’s signature brand of lubricant eye drops, Systane, as the first-ever Official Eye Care Partner of Complexity Gaming. Now more than ever, dry
GENEVA — Alcon announces the U.S. launch of the newest addition to its innovative portfolio of dry eye products – Systane Hydration Multi-Dose Preservative-Free (MDPF) Lubricant Eye Drops. With its proprietary HydroBoost Technology, this new preservative-free eye drop provides extra moisture for patients with sensitive dry eyes. DPF joins the fast-growing preservative-free segment of artificial tears,
GENEVA — Alcon announced that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C). As Alcon’s third Rx-to-OTC switch in the past twelve months, Pataday Once Daily Relief Extra Strength
FORT WORTH – Alcon announced on Tuesday the results of a new survey, rolled out in recognition of Dry Eye Awareness Month. The survey, conducted by research firm Ipsos among 1,005 nationally representative U.S. adults, uncovers the impact the COVID-19 pandemic is having on consumers’ screen time and how that impacts their perceptions on eye
GENEVA – Alcon announced Tuesday that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo, has been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the United States. Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch
Nearly 66 million (one in five) Americans suffer from itchy eyes caused by seasonal and/or perennial allergies. In any given year, pharmacists and health care professionals face questions during allergy season about itchy eye symptoms that can easily be confused with dry eye disease or viral infections. This year, many are now asking a new
FORT WORTH — Alcon announced that Pataday Once Daily Relief (olopatadine hydrochloride ophthalmic solution 0.2%) and Pataday Twice Daily Relief (olopatadine hydrochloride ophthalmic solution 0.1%) have been approved by the Food and Drug Administration (FDA) for sale over-the-counter (O-T-C) in the U.S. The Pataday brand features the No. 1 doctor-prescribed eye allergy itch relief ingredient,
FORT WORTH — Alcon is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1 contact lenses have
FORT WORTH — Alcon has launched a new art-focused campaign in honor of Cataract Awareness Month, which illustrates the impact cataracts can have on seeing color and encourages those diagnosed with cataracts to understand the benefits of cataract surgery. The campaign is part of Alcon’s continued commitment to educate patients about cataracts and treatment options.
FORT WORTH — Alcon, the global leader in eye care and a division of Novartis, announced Monday that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular lens implants. The acquisition furthers Alcon’s commitment to bring this innovative, accommodating lens to cataract patients throughout the world. Commercial availability
FORT WORTH — Alcon, a division of Novartis, is inviting consumers to change their eye color as part of the AIR OPTIX Colors contact lenses sweepstakes for a chance to go backstage at New York Fashion Week: The Shows in February 2019. To enter, people must wear or virtually try on one of 12 colors
